
Scientists warn climate change could cut crop yields up to a quarter, North America would be hit hardest
Climate change is on track to reduce by 11 percent in 2100 the yields that today provide two-thirds of humanity's calories from crops, even taking into account adaptation to a warming world, scientists said Wednesday.
As soon as 2050, this 'moderate' scenario in which greenhouse gas emissions peak around 2040 and slowly taper off -- a trajectory aligned with current trends -- would see global losses of nearly eight percent.
And if carbon pollution worsens, the loss of calories across the same six staples -- corn, wheat, rice, soybeans, sorghum and cassava -- rises to nearly a quarter by century's end, the researchers reported in Nature.
More generally, every additional degree Celsius of warming reduces the world's ability to produce food from these crops by 120 calories per person per day, or nearly five percent of current daily consumption, they calculated.
'If the climate warms by three degrees, that's basically like everyone on the planet giving up breakfast,' said co-author Solomon Hsiang, a professor at the Stanford Doerr School of Sustainability in California.
The steepest losses will occur at the extremes of the agricultural economy: in modern, Big Ag breadbaskets that currently enjoy some of the world's best growing conditions, and in subsistence farming communities that typically rely of small cassava harvests.
North America would be hit hardest, losing a fifth of yields by 2100 in the moderate carbon pollution scenario, and two-fifths if emissions from burning fossil fuels continue apace.
Working with more than a dozen scientists, Hsiang and co-leader Andrew Hultgren, an assistant professor at the University of Urbana-Champaign, sifted through data from more than 12,000 regions in 55 countries.
Erratic weather
Previous calculations of how a warming world will impact crop yields generally failed to consider the ways in which farmers would adapt, such as switching crop varieties, shifting planting and harvesting dates, and altering fertiliser use.
The scientists estimated such adjustments would offset about a third of climate related losses over the next 75 years in the scenario of rising emissions, but that residual impacts would still be devastating.
'Any level of warming, even when accounting for adaptation, results in global output losses for agriculture,' said Hultgren.
With the planet about 1.5C hotter than preindustrial levels in the late 1900s, farmers in many regions are already experiencing longer dry spells, unseasonable heatwaves and erratic weather that undermines yields.
The nutritional value of most crops also declines with hotter temperatures, earlier research has shown.
The study revealed sharp variations in the impact of global warming on different crops and regions.
In the 'worst-case' scenario of rising carbon emissions, corn yields would plummet 40 percent by 2100 across the grain belt of the United States, eastern China, central Asia, and the Middle East.
For soybeans, yields in the US would decline by half, and increase by a fifth in Brazil.
Wheat losses would drop by a fifth in eastern and western Europe, and by 30 to 40 percent in other wheat-growing regions: China, Russia and North America.
Cassava would be hit hard everywhere it's grown.
'Although cassava does not make up a large portion of global agricultural revenues, it is an important subsistence crop in low- and middle-income countries,' the researchers pointed out.
Among the six crops examined, rice is the only one that stands to benefit in a warmer climate, mainly due to warmer nights.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBC
7 hours ago
- CBC
Canada races to keep invasive grass carp at bay
Invasive grass carp reproduce in U.S. rivers that flow into Ontario's waters, which has Canadian biologists racing to contain the spread before they devour native plants and forever change ecosystems here.

National Post
8 hours ago
- National Post
Cascade Space Announces $5.9M Seed Funding to Build End-To-End Space Communication Platform
SAN FRANCISCO — Cascade Space, the platform for end-to-end communication system design, test, and operation, today announced that it has raised $5.9 million in seed funding. The round included participation from Nova Threshold, Undeterred Capital, Y Combinator, Night Capital, Olive Capital, Valkyrie Ventures, Karman Ventures, Palm Drive Capital, Garage Capital, TRAC, Aurelia Foundry, Hawktail, Pioneer Fund, Liquid 2 Ventures, and others. THIS CONTENT IS RESERVED FOR SUBSCRIBERS Enjoy the latest local, national and international news. Exclusive articles by Conrad Black, Barbara Kay and others. Plus, special edition NP Platformed and First Reading newsletters and virtual events. Unlimited online access to National Post. National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles including the New York Times Crossword. Support local journalism. SUBSCRIBE FOR MORE ARTICLES Enjoy the latest local, national and international news. Exclusive articles by Conrad Black, Barbara Kay and others. Plus, special edition NP Platformed and First Reading newsletters and virtual events. Unlimited online access to National Post. National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles including the New York Times Crossword. Support local journalism. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors The funding will accelerate the development of the Cascade Portal, a platform for satellite communication system design. Cascade recently released the spacelink Python library open-source. This library contains functions for communication system analysis that is used in the Cascade Portal implementation. 'Our mission at Cascade Space is to provide tools and infrastructure for spacecraft communication system design, test, and operations that will allow our customers to ship faster with the highest levels of mission assurance,' said Jacob Portukalian, co-founder and CEO of Cascade. 'Communication system design, test, and operation is a major bottleneck for space companies, especially those going to lunar and deep space. We have a team of veteran space engineers from SpaceX and Astra and we are stoked to be building the end-to-end platform to accelerate space exploration.' Cascade Space is a space communication system company. Founded in 2025, Cascade Space is building the platform for design, test, and operation for space communication systems. For more information, visit View source version on Jacob Portukalian Co-Founder / CEO jacob@


Globe and Mail
9 hours ago
- Globe and Mail
Boster Bio Revolutionizes IHC Services With Free Antibody Validation, Setting Industry Standards
Boster Bio pioneers free antibody validation, revolutionizing IHC services with guaranteed reagent reliability, setting new standards for reproducible research in biotech and pharmaceutical development. Boster Biological Technology (Boster Bio) is transforming the antibody industry with its reliable free antibody validation, providing precise staining and detection solutions for tissue samples. A leading provider of immunohistochemistry services (IHC services), the company has emerged as a game-changer for researchers demanding accuracy and transparency. With its commitment to antibody validation services that ensure reproducible results, Boster Bio addresses a critical pain point in biomedical research. Researchers no longer need to risk failed experiments due to untested reagents, as the company's approach ensures that every antibody meets high specificity and sensitivity standards before reaching the lab. Unlike competitors, Boster Bio provides detailed validation data upfront, allowing researchers to make informed decisions. The antibody validation process employs stringent testing, including Western blot, ELISA, and IHC cross-verification. Each antibody undergoes performance checks with openly accessible validation data, representing a notable milestone in the industry. Additionally, Boster Bio's responsive technical support team assists researchers in optimizing experiments, while flexible bulk and custom service options cater to diverse project needs. Fast shipping, a satisfaction guarantee, and openly shared validation protocols reinforce its commitment to scientific integrity. Combining cutting-edge technology with customer-centric policies, Boster Bio puts researchers first, setting a new standard for trust and efficiency in immunohistochemistry services and antibody supply. What sets it apart is its dedication to free antibody validation, a service typically offered by competitors for a fee. For more information, visit "Antibody reproducibility is a major challenge in life sciences. By offering free antibody validation, we eliminate guesswork and empower scientists with data-backed confidence in their reagents. This isn't just a service, it's our commitment to accelerating credible research," said CJ Xia, Founder of Boster Bio. With over 30 years of experience in antibody and immunoassay development, Boster Bio has established itself as a trusted leader in life science research. Serving researchers globally, the company has developed more than 20,000 high-quality antibodies and 2,000 ELISA kits. Backed by numerous peer-reviewed publications and citations in prestigious journals, Boster Bio has set industry benchmarks, earning recognition from academic and pharmaceutical institutions worldwide for its innovations in immunohistochemistry services and antibody validation. Boster Bio offers researchers advanced IHC protocols, offering both single and multiplex IHC/immunofluorescence panels tailored to research needs. Utilizing fully automated Leica Bond systems, the company ensures precision and reproducibility in staining while delivering fast turnaround times, typically just one to two weeks after sample receipt. With extensive experience supporting IHC for IND studies and regulatory submissions, Boster Bio is committed to helping researchers meet stringent compliance requirements. Additionally, the team specializes in developing custom IHC protocols optimized for specific targets and tissue types, enhancing detection sensitivity and accuracy. These capabilities make Boster Bio a trusted partner for high-quality, efficient, and regulatory-ready IHC solutions. Boster Bio excels in providing comprehensive IHC services and caters to the academic, pharmaceutical, and biotech sectors worldwide. Covering a wide range of applications, including cancer research, neuroscience, and immunology, the company offers access to over 3,000 pre-validated antibodies, ELISA kits, protein assays, and custom antibody development. By consistently delivering rigorously tested reagents with comprehensive validation data, Boster Bio continues to accelerate scientific discovery while maintaining exceptional standards of quality and reproducibility. For scientists prioritizing accuracy, Boster Bio's free antibody validation and comprehensive immunohistochemistry services offer an unmatched advantage, eliminating costly guesswork and ensuring reproducible results. About the Company: Boster Biological Technology (Boster Bio), based in Pleasanton, CA, is a leading provider of high-quality immunohistochemistry services and antibody validation solutions. Known for its free antibody validation, the company ensures researchers receive rigorously tested, reproducible antibodies, addressing a critical need in biomedical science. Offering ELISA kits, protein assays, and custom antibody development, Boster Bio serves academic, pharmaceutical, and biotech sectors worldwide. Media Contact Company Name: Boster Biological Technology Contact Person: CJ Xia Email: Send Email Phone: (888) 466-3604 Address: 3942 Valley Ave City: Pleasanton State: CA 94566 Country: United States Website: